Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients

被引:94
|
作者
Peterseim, DS
Cen, YY
Cheruvu, S
Landolfo, K
Bashore, TM
Lowe, JE
Wolfe, WG
Glower, DD
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 1999年 / 117卷 / 05期
关键词
D O I
10.1016/S0022-5223(99)70368-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of this study was to optimize selection criteria of biologic versus mechanical valve prostheses for aortic valve replacement. Methods: Retrospective analysis was performed for 841 patients undergoing isolated, first-time aortic valve replacement with Carpentier-Edwards (n = 429) or St Jude Medical (n = 412) prostheses. Results: Patients with Carpentier-Edwards and St Jude Medical valves had similar characteristics. Ten-gear survival was similar in each group (Carpentier-Edwards 54% +/- 3% versus St Jude Medical 50% +/- 6%; P =.4), Independent predictors of worse survival were older age, renal or lung disease, ejection fraction less than 40%, diabetes, and coronary disease. Carpentier-Edwards versus St Jude Medical prostheses did not affect survival (P =.4). Independent predictors of aortic valve reoperation were younger age and Carpentier-Edwards prosthesis. The linearized rates of thromboembolism were similar, but the linearized rate of hemorrhage was lower with Carpentier-Edwards prostheses (P <.01), Perivalvular leak within 6 months of operation was more likely with St Jude Medical than with Carpentier-Edwards prostheses (P =.02). Estimated 10-year survival free from valve-related morbidity was better for the St Jude Medical valve in patients aged less than 65 Sears and was better for the Carpentier-Edwards valve in patients aged more than 65 years. Patients with renal disease, lung disease tin patients more than age 60 years), ejection fraction less than 40%, or coronary disease had a life expectancy of less than 10 years. Conclusions: For first-time, isolated aortic valve replacement, mechanical prostheses should be consider ed in patients under age 65 years with a life expectancy of at least 10 years. Bioprostheses should be considered in patients over age 65 years or with lung disease tin patients over age 60 Sears), renal disease, coronary disease, ejection fraction less than 40%, or a life expectancy less than 10 years.
引用
收藏
页码:890 / 897
页数:8
相关论文
共 50 条
  • [21] Long-Term Outcomes of Veteran Patients After Transcatheter Aortic Valve Replacement
    Jneid, Hani
    Farmer, Douglas
    Kherallah, Riyad Y.
    Paniagua, David
    Denktas, Ali
    Kar, Biswajit
    Cornwell, Lorraine
    Blaustein, Alvin
    Preventza, Ourania
    Jimenez, Ernesto
    JOURNAL OF INVASIVE CARDIOLOGY, 2021, 33 (09): : E730 - E737
  • [22] Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis
    Girdauskas, Evaldas
    Disha, Kushtrim
    Borger, Michael A.
    Kuntze, Thomas
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (01): : 276 - 282
  • [23] Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement
    Chan, Vincent
    Lam, B-Khanh
    Rubens, Fraser D.
    Hendry, Paul
    Masters, Roy
    Mesana, Thierry G.
    Ruel, Marc
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (01): : 146 - 151
  • [24] Predicting Long-Term Outcomes After Aortic Valve Replacement
    Parikh, Puja B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 201 : 375 - 377
  • [25] Mechanical vs Bioprosthetic Aortic Valve Replacement in Patients on Dialysis: Long-term Outcomes
    Matsuura, Kaoru
    Yamamoto, Hiroyuki
    Miyata, Hiroaki
    Matsumiya, Goro
    Motomura, Noboru
    ANNALS OF THORACIC SURGERY, 2023, 116 (01): : 61 - 67
  • [26] Aortic valve replacement in octogenarians: operative outcome and long-term results
    Kolh, P. H.
    Kerzmann, A.
    Jacquart, J.
    Gerard, P.
    Limet, R.
    EUROPEAN HEART JOURNAL, 2005, 26 : 676 - 676
  • [27] Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement
    Lund, Ole
    Bland, Martin
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (01): : 20 - U41
  • [28] Mechanical Versus Biologic Prostheses for Surgical Aortic Valve Replacement in Patients 50 to 70
    Kyto, Ville
    Sipila, Jussi
    Ahtela, Elina
    Rautava, Paivi
    Gunn, Jarmo
    ANNALS OF THORACIC SURGERY, 2020, 110 (01): : 102 - 110
  • [29] Long-term outcome after valve replacement with the omnicarbon prosthesis
    di Summa, M
    Poletti, G
    Brero, L
    Centofanti, P
    La Torre, M
    Patanè, F
    Raggio, JMC
    Sanchez, FG
    Maroñas, JM
    Torregrosa, S
    Valera, FJ
    Caffarena, J
    JOURNAL OF HEART VALVE DISEASE, 2002, 11 (04): : 517 - 523
  • [30] Long-Term Outcome and Quality of Life After Biological Aortic Valve Replacement in Nonelderly Adults
    Petersen, Johannes
    Krogmann, Henry
    Reichenspurner, Hermann
    Girdauskas, Evaldas
    ANNALS OF THORACIC SURGERY, 2021, 111 (01): : 142 - 149